|Bid||1.20 x 800|
|Ask||1.50 x 800|
|Day's range||1.26 - 1.29|
|52-week range||1.23 - 6.00|
|PE ratio (TTM)||N/A|
|Earnings date||8 May 2018 - 14 May 2018|
|Forward dividend & yield||N/A (N/A)|
|1y target est||4.50|
On a per-share basis, the Los Angeles-based company said it had a loss of 15 cents. The company's shares closed at $1.89. A year ago, they were trading at $2.95. _____ This story was generated by Automated ...
The Los Angeles-based company said it had a loss of 16 cents per share. The cancer drug developer posted revenue of $100,000 in the period. For the year, the company reported that its loss narrowed to ...
On a per-share basis, the Los Angeles-based company said it had a loss of 19 cents. Losses, adjusted for non-recurring gains, were 33 cents per share. The company's shares closed at $1.93. A year ago, ...